Trials / Completed
CompletedNCT00036179
Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis
An Open-Label, Non-Comparative Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the safety and efficacy of FK463 in the treatment of patients with confirmed candidemia or invasive candidiasis.
Detailed description
This will be an open-label, non-comparative study of intravenous FK463. Enrollment will include at least 100 patients evaluable for efficacy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FK463 |
Timeline
- Start date
- 1999-02-27
- Primary completion
- 2002-01-27
- Completion
- 2002-01-27
- First posted
- 2002-05-09
- Last updated
- 2018-01-10
Locations
23 sites across 8 countries: Austria, France, Germany, Italy, Poland, Spain, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT00036179. Inclusion in this directory is not an endorsement.